HER2-Positive Endometrial Cancer: A Targeted Approach to Treatment
The role of HER2 status and targeted therapy with trastuzumab in advanced endometrial cancer, emphasizing the need for effective management of cardiac toxicities and comorbidities.
Stay updated with breaking news from Recurrent Disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The role of HER2 status and targeted therapy with trastuzumab in advanced endometrial cancer, emphasizing the need for effective management of cardiac toxicities and comorbidities.
Christian Marth, MD, PhD, and Bradley J. Monk, MD, FACS, FACOG, discuss data from the NRG GY018 and RUBY trials regarding the use of immunotherapies for the treatment of endometrial cancer.
Experts discuss the possibility to avoid use of chemotherapy by using immunotherapy.
Access a treatment regimen chart with information about therapies for pancreatic adenocarcinoma such as systemic chemotherapy and clinical trial options.
HMP Global Announces Distinguished Faculty Lineup for Inaugural Great Debates & Updates in Women’s Oncology Share Article Program features clinical insight from prominent experts in the fields of gynecological and breast cancers; two-day agenda will address hot topics in an interactive, engaging format “Delivered in the highly popular and uniquely interactive Great Debates & Updates format, this program will offer participants an engaging, educational opportunity,” said Kathleen N. Moore, MD, MS, and Conference Co-Chair of GDU Women’s Oncology. MALVERN,...